MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nmni.2023.101182

Медицинская библиотека · New microbes and new infections · 2023

Clinical utility of prior positive cultures to optimize empiric antibiotic therapy selection: A cross-sectional analysis.

Khasawneh Rawand A, Almomani Basima A, Al-Shatnawi Samah F, Al-Natour Lara

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite reduced infectious disease mortality and improved survival, infectious diseases continue to pose health threats due to their contagiousness, societal harm, and morbidity. Empiric antibiotic therapy, often prescribed without knowledge of the causative pathogen, faces challenges from rising antibiotic resistance. This study explores the potential of prior positive culture results to guide empiric antibiotic therapy.

METHODS

Data from King Abdullah University Hospital (Jan 2014-Dec 2019) included adult patients with recurrent bacterial infections (pneumonia, sepsis, UTIs, wounds). Excluded cases included: mixed infections, transfers, <14 days or >12 months between episodes. The study compared bacterial growth and sensitivity patterns between previous and recent cultures.

RESULTS

The study included 970 episodes from 650 patients, mainly UTIs (60.3%) and gram-negative bacteria (77.9%). The study found that (65.1%) of culture pairs matched. Empirical therapy was accurate in (71.8%) of cases. Further, accuracy of selected empiric antibiotic therapy was significantly predicted (p ​< ​0.001) by: type of infection, type of antibiotics, and concordance with prior microbiologic data. Multivariate logistic analysis showed blood culture as less predictive of pending identity (OR: 0.234, P ​< ​0.001) compared to urine culture; and prior affirmed gram negative bacterial culture was less predictive (OR: 0.606, P ​= ​0.021) compared to gram positive bacterial culture.

CONCLUSION

This study underscores the potential of prior positive culture results in guiding empiric antibiotic therapy, enhancing accuracy and identity agreement. Future research should explore this approach in different infection contexts and across multiple centers. Reducing the indiscriminate use of broad-spectrum antibiotics is essential to combat antibiotic resistance.

Для цитирования: Khasawneh Rawand A, Almomani Basima A, Al-Shatnawi Samah F, Al-Natour Lara. Clinical utility of prior positive cultures to optimize empiric antibiotic therapy selection: A cross-sectional analysis.. New microbes and new infections. 2023. DOI: 10.1016/j.nmni.2023.101182.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.